Cargando…

Increased risk of ischaemic heart disease after kidney donation

BACKGROUND: Previous reports suggest increased risk of hypertension and cardiovascular mortality after kidney donation. In this study we investigate the occurrence of ischaemic heart disease and cerebrovascular disease, diabetes and cancer in live kidney donors compared with healthy controls eligibl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haugen, Anders J, Hallan, Stein, Langberg, Nina E, Dahle, Dag Olav, Pihlstrøm, Hege, Birkeland, Kåre I, Reisæter, Anna V, Midtvedt, Karsten, Hartmann, Anders, Holdaas, Hallvard, Mjøen, Geir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035350/ https://www.ncbi.nlm.nih.gov/pubmed/33624826 http://dx.doi.org/10.1093/ndt/gfab054

Ejemplares similares

Endothelial Dysfunction and 6-Year Risk of Mortality in Kidney Transplant Recipients
por: Langberg, Nina Elisabeth, et al.
Publicado: (2021)

Symmetric Dimethylarginine as Predictor of Graft loss and All-Cause Mortality in Renal Transplant Recipients
por: Pihlstrøm, Hege, et al.
Publicado: (2014)

Exploring the potential effect of paricalcitol on markers of inflammation in de novo renal transplant recipients
por: Pihlstrøm, Hege Kampen, et al.
Publicado: (2020)

Neopterin is associated with cardiovascular events and all-cause mortality in renal transplant patients
por: Pihlstrøm, Hege, et al.
Publicado: (2014)

Should patients older than 65 years be offered a second kidney transplant?
por: Heldal, Kristian, et al.
Publicado: (2017)

Use of Statins in Kidney Transplant Recipients in Norway
por: Rønning, Marit, et al.
Publicado: (2022)

One-year protocol biopsies from ABO-incompatible renal allografts compared with a matched cohort of ABO-compatible allografts
por: Dörje, Christina, et al.
Publicado: (2015)

Urinary proteomic shotgun approach for identification of potential acute rejection biomarkers in renal transplant recipients
por: Loftheim, Håvard, et al.
Publicado: (2012)

Severe Mycophenolate Intoxication in a Solid Organ Transplant Recipient—No Intervention Actually Needed
por: Åsberg, Anders, et al.
Publicado: (2020)

Paricalcitol supplementation during the first year after kidney transplantation does not affect calcification propensity score
por: Ussif, Amin, et al.
Publicado: (2018)

The Salutary Blood Pressure of a Solitary Kidney
por: Dahle, Dag Olav, et al.
Publicado: (2020)

Hypertensive Living Kidney Donor Candidates: What’s the Risk?
por: Dahle, Dag Olav, et al.
Publicado: (2021)

Long-Term Risks of Kidney Donation: Age Known
por: Holdaas, H, et al.
Publicado: (2014)

Renal Cell Carcinoma and Kidney Transplantation: A Narrative Review
por: Dahle, Dag Olav, et al.
Publicado: (2021)

Resolution of Calciphylaxis After Urgent Kidney Transplantation in 3 Patients With End-Stage Kidney Failure
por: Nordheim, Espen, et al.
Publicado: (2016)

Are Octogenarians With End-Stage Renal Disease Candidates for Renal Transplantation?
por: Lønning, Kjersti, et al.
Publicado: (2016)

Predicting donor, recipient and graft survival in living donor kidney transplantation to inform pretransplant counselling: the donor and recipient linked iPREDICTLIVING tool – a retrospective study
por: Haller, Maria C., et al.
Publicado: (2020)

Exposure to Mycophenolate and Fatherhood
por: Midtvedt, Karsten, et al.
Publicado: (2017)

Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients – a pilot study
por: Bremer, Sara, et al.
Publicado: (2009)

Induction with interleukin-2 antagonist for transplantation of kidneys from older deceased donors: an observational study
por: Heldal, Kristian, et al.
Publicado: (2013)

First Scandinavian Protocol for Controlled Donation After Circulatory Death Using Normothermic Regional Perfusion
por: Foss, Stein, et al.
Publicado: (2018)

Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes Following Preemptive Versus Prophylactic Management
por: Blom, Kjersti B., et al.
Publicado: (2023)

Improved Health-Related Quality of Life in Older Kidney Recipients 1 Year After Transplantation
por: Lønning, Kjersti, et al.
Publicado: (2018)

Elevated Terminal C5b-9 Complement Complex 10 Weeks Post Kidney Transplantation Was Associated With Reduced Long-Term Patient and Kidney Graft Survival
por: Witczak, Bartlomiej J., et al.
Publicado: (2021)

Health‐related quality of life in Norwegian adults with Fabry disease: Disease severity, pain, fatigue and psychological distress
por: Pihlstrøm, Hege Kampen, et al.
Publicado: (2021)

The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients
por: Lunde, Ingrid, et al.
Publicado: (2014)

Poor Physical Function Trajectory Predicts Impaired Patient Survival in Older Recipients of Deceased Donor Kidneys: A Prospective Cohort Study
por: Tsarpali, Vasiliki, et al.
Publicado: (2022)

Humoral vaccine response and breakthrough infections in kidney transplant recipients during the COVID-19 pandemic: a nationwide cohort study
por: Hovd, Markus, et al.
Publicado: (2023)

Kidney Transplant Recipient Behavior During the Early COVID-19 Pandemic: A National Survey Study in Norway
por: Blom, Kjersti B., et al.
Publicado: (2021)

Blood Pressure Treatment in Kidney Transplant Recipients—Can We Improve?
por: Onsøien, Mari O., et al.
Publicado: (2021)

Inclusion of CYP3A5 genotyping in a nonparametric population model improves dosing of tacrolimus early after transplantation
por: Åsberg, Anders, et al.
Publicado: (2013)

The impact of demographic and clinical characteristics on the trajectories of health-related quality of life among patients with Fabry disease
por: Sigurdardottir, Solrun, et al.
Publicado: (2021)

A Comorbidity Index and Pretransplant Physical Status Predict Survival in Older Kidney Transplant Recipients: A National Prospective Study
por: Tsarpali, Vasiliki, et al.
Publicado: (2022)

Low level of MAp44, an inhibitor of the lectin complement pathway, and long-term graft and patient survival; a cohort study of 382 kidney recipients
por: Smedbråten, Julia, et al.
Publicado: (2016)

Importance of hematocrit for a tacrolimus target concentration strategy
por: Størset, Elisabet, et al.
Publicado: (2013)

Everolimus and Malignancy after Solid Organ Transplantation: A Clinical Update
por: Holdaas, Hallvard, et al.
Publicado: (2016)

Tacrolimus Measured in Capillary Volumetric Microsamples in Pediatric Patients—A Cross-Validation Study
por: Kindem, Ingvild Andrea, et al.
Publicado: (2021)

Kidney transplantation: an attractive and cost-effective alternative for older patients? A cost–utility study
por: Heldal, Kristian, et al.
Publicado: (2019)

Immunosuppression Adherence in Stable Kidney Transplant Patients Converted From Immediate- to Prolonged-Release Tacrolimus in Clinical Practice: A Norwegian Study
por: Abedini, Sadollah, et al.
Publicado: (2018)

Patient selection for islet or solid organ pancreas transplantation: experiences from a multidisciplinary outpatient-clinic approach
por: Nordheim, Espen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_aqpmmg22del89hnrku00nufqv7